Control of Sleep and Wakefulness in Health and Disease - Progress in Molecular Biology and Translational Science - page 150

various modulators and how they interact to produce both normal and path-
ological forms of sleep must be considered a work in progress.

REFERENCES
1. Bremer F. Cerveau isole et physiologie du sommeil. C R Soc Biol (Paris) .

1935;118:1235-1241.
2. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG.
Electroencephalogr Clin Neurophysiol . 1949;1:455-473.
3. Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping
and aroused brain. Science . 1993;262:679-685.
4. Trulson ME, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level
of behavioral arousal. Brain Res . 1979;163:135-150.
5. Zeitzer JM, Maidment NT, Behnke EJ, et al. Ultradian sleep-cycle variaiton of serotonin
in the human lateral ventricle. Neurology . 2002;59:1272-1274.
6. Riemann D. Insomnia and comorbid psychiatric disorders. Sleep Med . 2007;8(Suppl. 4):
S15-S20.
7. Sharpley AL, Cowen PJ. Effect of pharmacologic treatments on the sleep of depressed
patients. Biol Psychiatry . 1995;37:85-98.
8. Aston-Jones G, Rajkowski J, Cohen J. Role of locus coeruleus in attention and behav-
ioral flexibility. Biol Psychiatry . 1999;46:1309-1320.
9. Tsai MH, Huang YS. Attention-deficit/hyperactivity disorder and sleep disorders in
children. Med Clin North Am . 2010;94:615-632.
10. Mignot E. A hundred years of narcolepsy research. Arch Ital Biol . 2001;139:207-220.
11. Broughton R, Valley V, Aguirre M, Roberts J, Suwalski W, DunhamW. Excessive day-
time sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspec-
tive. Sleep . 1986;9:205-215.
12. Zeitzer JM, Nishino S, Mignot E. The neurobiology of hypocretins (orexins), narco-
lepsy and therapeutic interventions. Trends Pharmacol Sci . 2006;27:368-374.
13. Blanco-Centurion C, Gerashchenko D, Shiromani PJ. Effects of saporin-induced lesions
of three arousal populations on daily levels of sleep and wake. J Neurosci .

2007;27:14041-14048.
14. Fried I, Wilson CL, Morrow JW, et al. Increased dopamine release in the human amyg-
dala during performance of cognitive tasks. Nat Neurosci . 2001;4:201-206.
15. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from
an unlikely source: PD. Neurology . 2002;58:341-346.
16. Trulson ME, Preussler DW, Howell GA. Activity of substantia nigra units across the
sleep-waking cycle in freely moving cats. Neurosci Lett . 1981;26:183-188.
17. Lu J, Jhou TC, Saper CB. Identification of wake-active dopaminergic neurons in the
ventral periaqueductal gray matter. J Neurosci . 2006;26:193-202.
18. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in
patients with Parkinson's disease. Mov Disord . 1998;13:895-899.
19. Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent
development of Parkinson disease. Neurology . 2005;65:1442-1446.
20. Siegel JM. The neurobiology of sleep. Semin Neurol . 2009;29:277-296.
21. Taepavarapruk N, Taepavarapruk P, John J, et al. State-dependent changes in glutamate,
glycine, GABA, and dopamine levels in cat lumbar spinal cord. J Neurophysiol .

2008;100:598-608.
22. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian dis-
order in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement
sleep behaviour disorder. Neurology . 1996;46:388-393.